XML 38 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Operations and Comprehensive (loss) Income

In May 2023, the Company completed the disposal of its social E-commerce business, which was operated by the consolidated VIEs. As a result, the following financial statement amounts were included in net income (loss) from discontinued operation in the accompanying consolidated statements of operations and comprehensive (loss) income and assets/liabilities held for sale in consolidated balance sheet.

 

   For the Six Months Ended
September 30,
 
   2024   2023 
   USD   USD 
Net revenues       698 
Net loss       3,905 
Schedule of Revenue

For the six months ended September 30, 2024 and 2023, the revenue of the Company illustrated as below:

 

   For Six Months Ended September 30, 
   2024   2023 
   USD   USD 
Revenue        

Revenue from sales of medical devices

   415,020    894,768 

Revenue from marketing promotion service

   6,520,930     
Total revenues   6,935,950    894,768 
Tax and surcharges   (1,759)   (1,185)
Net Revenues   6,934,191    893,583 
Schedule of Noncontrolling Interest

As of September 30, 2024 and March 31, 2024, noncontrolling interest consist of the following:

 

   As of
September 30,
   As of
March 31,
 
   2024   2024 
   USD   USD 
We Healthy   50,849    56,810 
Tianjin Wangyi Cloud   36,474    
 
Total   87,323    56,810 
Schedule of Spot Exchange Rates and Average Exchange Rates

Spot exchange rates and average exchange rates were used in the translation of the condensed consolidated financial statements.

 

   For the
Six Months Ended
September 30,
 
   2024   2023 
US Exchange Rate        
Period-end RMB   7.0176    7.2960 
Period average RMB   7.2023    7.1287